Bulk Suggestion
Bulk ID:
mrvhyte/06.01.25-05:38AM
Accepted at: Jun, 10, 2025
12:49 a.m.
Author:
mrvhyte
Co-authors:
Stapedius
Related Deck:
1675118865074
Accepted
Rationale for new note
Additional cards on hypertension from eTG
Text
The first-line drug choice for management of hypertension in a patient with {{c1::Heart failure with reduced ejection fraction, CKD or post-MI::3}} is:
{{c2::ACEI or ARB}}
{{c2::ACEI or ARB}}
Text
The first-line drug choice for management of <b>hypertension</b> in a patient with {{c1::Heart failure with reduced ejection fraction, CKD or post-MI::3}} is:<br><br>{{c2::ACEI or ARB}}
Extra
Extra
<img src="0156aabd326256ff1bffcc71d6fbae10.webp">
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
Oxford Handbook
Empty field
Oxford Handbook
First Aid
Empty field
First Aid
AMBOSS
Empty field
AMBOSS
eTG Complete
eTG Complete
<img src="d3ee50aed7cf1767c81a317d02cb3f06.webp">
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Source
<a href="https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Cardiovascular&topicfile=cardiovascular-disease-risk-stratification&guidelinename=auto§ionId=c_CVG_Hypertension-and-blood-pressure-reductiontopic_8#c_CVG_Hypertension-and-blood-pressure-reductiontopic_8">https://app-tg-org-au.ap1.proxy.openathens.net/viewTopic?etgAccess=true&guidelinePage=Cardiovascular&topicfile=cardiovascular-disease-risk-stratification&guidelinename=auto&sectionId=c_CVG_Hypertension-and-blood-pressure-reductiontopic_8#c_CVG_Hypertension-and-blood-pressure-reductiontopic_8</a> Accessed Jun 1, 2025
One by one
Empty field
One by one
Tags
#Malleus_CM::#eTG_Complete::Cardiovascular::Blood_pressure_reduction::Hypertension_and_blood_pressure_reduction
#Malleus_CM::#Question_Banks::eMedici::0-999::60
#Malleus_CM::#Question_Banks::eMedici::1000-1999::1762
#Malleus_CM::#Resources_by_Rotation::General_Practice
#Malleus_CM::#Resources_by_Rotation::Indigenous_Health
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Cardiology
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine
#Malleus_CM::#Subjects::Cardiology::06_Vascular_Pathology::01_Hypertension::Essential_Hypertension::10_Management
#Malleus_CM::#Yield::High
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Captopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Enalapril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Fozinopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Fosinopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Lisinopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Perindopril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Quinapril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Ramipril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::02_ACE_inhibitors::Trandolapril::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Candesartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Eprosartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Drug::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Irbesartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Losartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Olmesartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Telmisartan::03_Indications
#Malleus_CM::#Pharmacology::08_Cardiovascular_drugs::03_Antihypertensives::03_Sartans::Valsartan::03_Indications